Prostate cancer as a model for tumour immunotherapy
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-08-01 / Nat. Rev. Immunol. 2010 Aug;10(8):580-93Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy
/in Dendritic Cells, International Publications /von 2010-08-01 / BioSystems 2010 Aug;101(2):117-26Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-07-27 / Pigment Cell Melanoma Res 2010 Oct;23(5):607-19Human myeloid dendritic cells for cancer therapy: does maturation matter?
/in Dendritic Cells, International Publications /von 2010-07-19 / Vaccine 2010 Jul;28(32):5153-60Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination
/in Acute Leukemia, Dendritic Cells, International Publications /von 2010-07-14 / Proc. Natl. Acad. Sci. U.S.A. 2010 Aug;107(31):13824-9Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-07-07 / Br. J. Haematol. 2010 Sep;150(5):554-64Advances in cellular therapy for the treatment of thyroid cancer
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2010-06-29 / J Oncol 2010;2010:179491Anti-HER2 vaccines: new prospects for breast cancer therapy
/in Breast Cancer, Dendritic Cells, International Publications /von 2010-06-08 / Cancer Immunol. Immunother. 2010 Sep;59(9):1295-312INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect
/in Dendritic Cells, International Publications, SCLC /von 2010-06-01 / Expert Opin Biol Ther 2010 Jun;10(6):983-91IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de